During a Case-Based Roundtable® event, Daniel A. Ermann, MD, discussed evaluation and treatment for a patient with relapsed ...

This trial was for people with chronic myeloid leukaemia. It looked at adding a targeted drug to the targeted drug people were already taking. Mortality rates for chronic myeloid leukaemia in the UK ...

Two posters presented at the 2024 American Society of Hematology meeting evaluated overall survival and cost-offset of ...

Rocker Mike Peters debuts the music video for his band The Alarm's song "Transition" as he searches for a donor amid a ...

Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...

Frontline tyrosine kinase inhibitors are well-established for chronic myelogenous leukemia, but some patients experience inadequate response or adverse events, highlighting the need for novel ...

Most patients with chronic lymphocytic leukemia eventually relapse. A bispecific antibody drug may give them "another can to ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

Carlsbad resident Jim Plotkin was diagnosed with leukemia back in 2018. While going through treatment, he continued to play ...

Aucatzyl is a chimeric antigen receptor (CAR) T-cell therapy, a type of therapy that uses genetic modification to train the ...